These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8018410)
1. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines. Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410 [TBL] [Abstract][Full Text] [Related]
2. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines. Civoli F; Daniel LW Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778 [TBL] [Abstract][Full Text] [Related]
3. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells. Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759 [TBL] [Abstract][Full Text] [Related]
5. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells. Shoji M; Raynor RL; Fleer EA; Eibl H; Vogler WR; Kuo JF Lipids; 1991 Feb; 26(2):145-9. PubMed ID: 2051897 [TBL] [Abstract][Full Text] [Related]
6. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518 [TBL] [Abstract][Full Text] [Related]
7. Antiinvasive activity of hexadecylphosphocholine in vitro. Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities. Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284 [TBL] [Abstract][Full Text] [Related]
9. Ether lipids inhibit the effects of phorbol diester tumor promoters. Daniel LW; Etkin LA; Morrison BT; Parker J; Morris-Natschke S; Surles JR; Piantadosi C Lipids; 1987 Nov; 22(11):851-5. PubMed ID: 3444377 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Heesbeen EC; Verdonck LF; Staal GE; Rijksen G Biochem Pharmacol; 1994 Apr; 47(9):1481-8. PubMed ID: 8185658 [TBL] [Abstract][Full Text] [Related]
11. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB. Fleer EA; Berkovic D; Grunwald U; Hiddemann W Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699 [TBL] [Abstract][Full Text] [Related]
12. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines. Wang YZ; Chang YB; Xing C; Fu D Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183 [TBL] [Abstract][Full Text] [Related]
13. Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation of human leukemia HL60 and KG-1 cells. Shoji M; Raynor RL; Berdel WE; Vogler WR; Kuo JF Cancer Res; 1988 Dec; 48(23):6669-73. PubMed ID: 3180076 [TBL] [Abstract][Full Text] [Related]
14. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D. Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456 [TBL] [Abstract][Full Text] [Related]
15. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Uberall F; Oberhuber H; Maly K; Zaknun J; Demuth L; Grunicke HH Cancer Res; 1991 Feb; 51(3):807-12. PubMed ID: 1846318 [TBL] [Abstract][Full Text] [Related]
16. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha. Aroca JD; Sánchez-Piñera P; Corbalán-García S; Conesa-Zamora P; de Godos A; Gómez-Fernández JC Eur J Biochem; 2001 Dec; 268(24):6369-78. PubMed ID: 11737191 [TBL] [Abstract][Full Text] [Related]
17. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues. Berkovic D; Haase D; Hiddemann W; Fleer EA J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427 [TBL] [Abstract][Full Text] [Related]
18. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes. Samadder P; Arthur G Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C is not involved in cholesterol-induced resistance to synthetic ether lipids. Diomede L; Salmona M; Lamorte G; Piovani B; Sozzani S Anticancer Res; 1993; 13(5A):1331-4. PubMed ID: 8239503 [TBL] [Abstract][Full Text] [Related]
20. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine. Boggs K; Rock CO; Jackowski S Biochim Biophys Acta; 1998 Jan; 1389(1):1-12. PubMed ID: 9443598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]